The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation

The first two and last authors had an equal contribution. Background: The Disease-Risk Index (Armand et al., Blood 2014) is an established system for risk stratification of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). However, it was developed in patients transplanted approximately a decade ago, does not incorporate prognostic molecular data in acute myeloid leukemia (AML), and is not inclusive of several...